COVID-19 Vaccine Payment Update: What Billing Teams Need to Know for 2026-2027


 

Preparing for a new vaccination season involves more than updating inventory. Billing teams must also confirm that product codes, payment allowances, and effective dates match the vaccines being administered.

CMS has published national payment allowances for the 2026–2027 COVID-19 vaccine season. The six product allowances below take effect for dates of service beginning August 27, 2026.

For practices providing vaccinations in patients’ homes, the update also provides an opportunity to review the separate requirements for additional in-home administration payment.

Match the Product to the Payment Allowance

COVID-19 vaccines have different formulations and doses. Selecting a code based solely on the manufacturer can lead to an incorrect claim. Staff should confirm the specific product administered and use the applicable code for that formulation.

CPT® codeProduct and abbreviated formulationNational payment allowance
91304Novavax Nuvaxovid, 5 mcg/0.5 mL$232.218
91319Pfizer Comirnaty, 10 mcg/0.3 mL$103.330
91320Pfizer Comirnaty, 30 mcg/0.3 mL$230.405
91321Moderna Spikevax, 25 mcg/0.25 mL$172.967
91322Moderna Spikevax, 50 mcg/0.5 mL$172.967
91323Moderna mNEXSPIKE, 10 mcg/0.2 mL$252.225

Descriptions are abbreviated for reference and do not replace complete code descriptors or product eligibility requirements. Amounts retain the precision published by CMS.

Separate Vaccine Product Payment From Administration

The vaccine product and the work of administering it are separate billing components. CMS lists CPT code 90480 for COVID-19 vaccine administration, with a published allowance of $44.95, and HCPCS code M0201 for qualifying additional in-home payment, with a listed allowance of $39.90.

Practices should consult the applicable geographically adjusted administration payment files for the date and location of service. The listed amounts should not be treated as a guarantee of an identical payment in every locality.

When an In-Home Vaccination Qualifies

Medicare’s additional in-home payment recognizes the resources needed to reach patients who have difficulty obtaining vaccination outside their homes. Clinical limitations, transportation problems, and other access barriers may support eligibility.

The medical record should explain the patient’s circumstances. An address alone does not establish why an in-home vaccination was necessary.

The COVID-19 in-home payment began in June 2021. Effective January 1, 2024, Medicare extended additional in-home payment to qualifying influenza, hepatitis B, and pneumococcal vaccinations.

Report M0201 With the Administration Service

For an eligible COVID-19 vaccination at home, CMS instructs providers to report both 90480 and M0201.

The additional payment is limited to once per patient per date of service in that home, even when the patient receives other covered Part B preventive vaccines during the visit. Each vaccine dose may still qualify for its applicable administration payment.

For example, administering both a COVID-19 vaccine and an influenza vaccine does not create two additional in-home payments for the same patient.

Watch the Visit Purpose and Location

The additional payment applies to visits devoted to qualifying preventive vaccinations. It should not be added when another Medicare service is provided and billed in the same home on the same date.

Location also matters. A Medicare skilled nursing facility or Medicaid nursing facility does not qualify as a home for this additional payment, even when it is the patient’s permanent residence.

For practices scheduling home visits, these conditions should be reviewed before the claim reaches the billing queue. Identifying a nonqualifying setting or another billable service early can prevent an unsupported additional charge.

Apply Group Living Limits Carefully

Vaccination events in group living settings require attention to both the number of patients vaccinated at the location and the particular home unit or communal space involved.

When fewer than 10 patients receive a vaccine at the same group living location on the same day, CMS permits additional in-home payments for eligible patients, subject to a combined maximum of five per home unit or communal space.

When 10 or more patients are vaccinated at the location that day, the additional payment is limited to once per home, whether that home is an individual unit or a communal space. These limits concern the additional in-home payment rather than the standard administration payment for each dose.

Review the Workflow Before Claims Go Out

A useful seasonal review connects clinical documentation, inventory, and billing. Confirm the vaccine formulation against the selected code, verify the date-of-service allowance, and review the documentation supporting any M0201 charge.

CMS also provides a seasonal NDC-to-HCPCS crosswalk to help organizations match products with reporting codes. Because pricing resources may be updated during the season, practices should check the latest available files when maintaining their billing systems.

Accurate vaccine billing depends on getting each component right: the product, administration service, setting, and any additional payment. Reviewing those elements together helps practices submit claims that reflect the care delivered.

Sources

 

Was this article helpful?

Your feedback goes directly to our editorial team and helps us decide what to cover next.